Showing results (401-410 of 1,769) with videos related to
Sort By:
Pageof 177
Gynecologic Oncology Reports|March 5, 2026
Symptom triad of primary cervical rhabdomyosarcomas as seen in a Nigerian tertiary hospital: A case seriesAisha Mustapha, Hauwa Gumbi, Asma Irshad, et al.Gynecologic Oncology Reports|February 27, 2026
Acute myocardial infarction caused by coronary tumor embolism from uterine leiomyosarcoma: a case reportYumi Shirasu, Kohei Tamura, Miki Shinohara, et al.Gynecologic Oncology Reports|February 26, 2026
A phase I dose-escalation study of Lobaplatin combined with paclitaxel in platinum-sensitive recurrent ovarian epithelial carcinoma: preliminary safety and tolerability supporting clinical trial dosingDongling Zou, Yi Gong, Yingjie Yang, et al.Gynecologic Oncology Reports|October 16, 2024
Malignant STK11 adnexal tumor harboring a somatic mutation in a woman previously diagnosed with mesothelioma, a case reportChristina R Rutherford, Taylor A Rives, Dava W Piecoro, et al.Gynecologic Oncology Reports|May 7, 2026
Malignant transformation of a testosterone-secreting ovarian steroid cell tumor: a case reportRavi Desai, Daniel Bravo, Pelin Onur, et al.Gynecologic Oncology Reports|March 11, 2026
Unilateral cervical carcinoma in a septate uterus with double cervix: A case report and literature reviewCamilla Bandeira Soares, Nick M Spirtos, Joao Jabbur Stern, et al.Gynecologic Oncology Reports|June 12, 2026
Trastuzumab deruxtecan (T-DXd) in HER2-expressing gynecological malignancies: Clinical evidence, safety profile, and future directionsHeena Arshad, Inamullah Arshad, Hamza Massab Rehman, et al.Gynecologic Oncology Reports|June 4, 2026
Single-port robotic resection of gliomatosis peritonei following immature ovarian teratoma in an adolescent: A case reportQingchi Zhang, Lingling Sun, Kuiran DongGynecologic Oncology Reports|June 15, 2026
Evaluation of anaphylactic reactions involving carboplatin and paclitaxel reported to the FDA from 1970 to 2023Halle Petrie, Taryn Boucher, Marta A Crispens, et al.Gynecologic Oncology Reports|June 30, 2023
A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factorsChunli Fu, Cong Wang, Qiuhong Qian, et al.Pageof 177